Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock witnessed some profit taking at higher levels, ending 6% below listing price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback